Trisubstituted Phenolic Compounds as Inhibitors of Acetylcholinesterase and Amyloid Beta Aggregate Formation

Author(s): Caroline M. Peckels, Nathan S. Alexander, Gina N. Wilson, Joel M. Karty, Kathryn M. Matera

Journal Name: Current Enzyme Inhibition

Volume 9 , Issue 1 , 2013

Become EABM
Become Reviewer


Neurophysiological indicators of Alzheimer’s disease include the presence of aggregated amyloid-beta (Aβ) peptide plaques and low levels of the neurotransmitter, acetylcholine, resulting in cognitive impairment. Acetylcholinesterase has been implicated in not only the aggregation of extracellular Aβ peptides through the enzyme’s peripheral anionic site, but also the hydrolysis of acetylcholine at its catalytic active site. Two components in a methanolic extract of black walnuts (Juglians nigra), gallic and ellagic acids, were found to prevent aggregation of Aβ peptides in the presence of acetylcholinesterase and to disaggregate previously formed oligomers. In addition, both compounds inhibited acetylcholinesterase activity, thus retaining higher acetylcholine concentrations. Analysis of phenolic structures related to gallic acid indicated that 1,3,5-trisubstituted phenolic rings conferred these inhibitory effects on acetylcholinesterase, and thus may provide a structural model on which to design dual inhibitors for both acetylcholinesterase catalytic activity and Aβ aggregation and disaggregation.

Keywords: Acetylcholinesterase, aggregation, amyloid-beta, phenol, dual inhibitors, Alzheimer’s disease.

promotion: free to download

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2013
Page: [67 - 74]
Pages: 8
DOI: 10.2174/1573408011309010009

Article Metrics

PDF: 15